Hemato Oncology Testing Market Size, Share, Future Challenges, Revenue, Demand, Opportunity, Analysis and Industry, Forecast 2025 - PowerPoint PPT Presentation

About This Presentation
Title:

Hemato Oncology Testing Market Size, Share, Future Challenges, Revenue, Demand, Opportunity, Analysis and Industry, Forecast 2025

Description:

The rise in the prevalence of hematologic cancer, increment in knowledge of precision medicine and the increase in the amount of assays are likely to result in the rapid growth of the oncology research industry in the forecast years. – PowerPoint PPT presentation

Number of Views:55
Slides: 7
Provided by: Thomashinds
Category: Other

less

Transcript and Presenter's Notes

Title: Hemato Oncology Testing Market Size, Share, Future Challenges, Revenue, Demand, Opportunity, Analysis and Industry, Forecast 2025


1
Hemato Oncology Testing Market
  • Size 2018, by Product (Service and Assay Kits),
    by Indication (Leukemia, Lymphoma, Other
    Cancers), Technology (NGS, PCR IHC, Cytogenetics,
    Others), End User (Hospitals, Laboratories,
    Academic Research Institutes, Others), Region
    and Forecast 2019 to 2025

Single Use License US 4400
Request Sample
2
Global Hemato Oncology Testing Market To Cross
USD 4.39 Billion By 2025
  • The global hemato oncology testing market is
    anticipated to cross USD 4.39 billion by 2025,
    growing at a CAGR of over 13. Increasing
    prevalence of blood cancer amongst children is
    anticipated to drive the demand for test kits in
    the coming years.
  • Adroit Market Research report on global hemato
    oncology testing market gives a holistic view of
    the market from 2015 to 2025, which includes
    factors such as market drivers, restraints,
    opportunities, challenges and regulatory
    scenario. The market has been studied for
    historic years from 2015 to 2017, with the base
    year of estimation as 2018 and forecast from 2019
    to 2025. The report covers the current status and
    future traits of the market at global as well as
    country level. In addition, the study also
    assesses the market competition with Porter's
    five forces analysis and positions the key
    players based on their product portfolio,
    geographic footprint, strategic initiatives and
    overall revenue. Prominent players operating in
    the global hemato oncology testing market have
    been studied in detail.
  • According to the estimates of the Leukemia
    Lymphoma Society, during 2019, over 82,000 cases
    of lymphoma will be diagnosed alone in the U.S.,
    the country will also observe more than 8,000 and
    74,000 cases of Hodgkin Non-Hodgkin Lymphoma.
    With advancements in detection tests, the
    survival rate has escalated twice in past few
    years. High awareness rates coupled with NGOs
    working to make people knowledgeable about
    symptoms, the consumption of testing kits is
    likely to rise in coming years.
  • In terms of product, services accounted for
    noticeable market share in 2018 and is
    anticipated to maintain its position compared to
    assay kits. Additionally, in terms of technology
    NGS is anticipated to emerge as the fastest
    growing segment compared to others.

3
Global Hemato Oncology Testing Market To Cross
USD 4.39 Billion By 2025
  • In terms of geography, Asia Pacific is likely to
    emerge as the most promising regional market by
    2025. Easing of drug policies between India and
    china is likely to increase the trade of medical
    supplies within these countries this is
    anticipated to attract more companies to invest
    in the region. Such factors are likely to drive
    the Asia Pacific market in the coming years.
  • Key vendors in the market include ARUP
    Laboratories Inc., Invivoscribe, Inc, Thermo
    Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd,
    Abbott Laboratories, Adaptive Biotechnologies,
    ArcherDx, Inc., MolecularMD , etc. Increasing
    spending on RD by tier 1 companies has been a
    successful strategy for them in order to maintain
    their market position. For instance, Roche has
    been investing around 11-13 of their revenues
    in RD, also majority of the sales for the
    company has been from APAC. As a result of which,
    the company was successful in developing RealTime
    IDH1 and RealTime IDH2 PCR kits for rapid
    detection of the medical condition. Such
    strategies are anticipated to improve the rate of
    diagnosis and reduce the global economic burden
    of the disease in coming years.
  • Browse the complete report on _at_
    https//www.adroitmarketresearch.com/industry-repo
    rts/hemato-oncology-testing-market

4
Segment Overview of Global hemato oncology
testing market
  • Product Overview, 2015-2025 (USD Million)
  • Services
  • Assay Kits
  • Indication Overview, 2015-2025 (USD Million)
  • Leukemia
  • Acute Myeloid Leukemia
  • Acute Lymphocytic Leukemia
  • Others
  • Lymphoma
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Others
  • Technology Overview, 2015-2025 (USD Million)
  • Cytogenetics.
  • NGS
  • PCR
  • IHC

5
Segment Overview of Global hemato oncology
testing market
  • End User Overview, 2015-2025 (USD Million)
  • Hospitals
  • Clinical Laboratories
  • Academic Research Institutes
  • Others
  • Regional Overview, 2015-2025 (USD Million)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa
  • Purchase a single user copy of the global hemato
    oncology testing market report_at_
    https//www.adroitmarketresearch.com/researchrepor
    t/purchase/1512

6
About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email sales_at_adroitmarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com